Drug Trial Radar · NCT03547583
Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF
Last checked: Nov 20, 2026Latest source record: Jan 6, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
789
Actual
Start
Jun 15, 2018
Primary completion
Oct 15, 2019
Study completion Nov 4, 2019
Sponsor
- Lead sponsor
- BayerBayer (BAYRY)
- Sponsor type
- Industry
- Collaborators
- Merck Sharp & Dohme LLC; Canadian VIGOUR Centre; Duke Clinical Research Institute
- First posted
- Jun 6, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary hypothesis in this trial is that the treatment with vericiguat 10 mg or 15 mg in patients with HFpEF improves the KCCQ PLS (Kansas City Cardiomyopathy Questionnaire Physical limitation score) compared to placebo after 24 weeks of treatment.
Conditions
- Chronic Heart Failure With Preserved Ejection Fraction
Interventions
Vericiguat (BAY1021189) 2.5 mg, 5 mg or 10 mg IR tabletsDrug
Oral use. Vericiguat, which will be started at 2.5 mg at randomization and up-titrated to 5 mg at week 2, and to 10 mg at week 4, with sham titration or up-titration to 15 mg at week 6.
PlaceboDrug
Placebo and sham up-titration at weeks 2, 4, and 6
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in KCCQ Physical Limitation Score From Baseline to Week 24Time frame: From baseline to Week 24
Locations
177 sites in 21 countries. Site status is shown where the registry gives one.
WestSide Medical
Beverly Hills, California
Capitol Interventional Cardiology
Carmichael, California
Interventional Cardiology Medical Group
West Hills, California
Penrose-St. Francis Health Services
Colorado Springs, Colorado
Cardiology Associates of Fairfield County, PC
Trumbull, Connecticut
Cardiology Associates Of South Florida PA
Boynton Beach, Florida
Cardiovascular and Vein Center of Florida
Bradenton, Florida
Cardiology Associates Research Company
Daytona Beach, Florida
LifeSpring Research Foundation, LLC
Miami, Florida
Southwest Florida Research
Naples, Florida
East Coast Institute for Research, LLC
Saint Augustine, Florida
Cardiology Partners
Wellington, Florida
Fox Valley Clinical Research Center, LLC
Aurora, Illinois
Advocate Condell Medical Center
Libertyville, Illinois
Reid Health
Richmond, Indiana
Research Integrity, LLC
Owensboro, Kentucky
Heart Clinic of Hammond
Hammond, Louisiana
Anne Arundel Health System
Annapolis, Maryland
Henry Ford Health System
Detroit, Michigan
Riser Medical Associates
Picayune, Mississippi
St. Louis Heart & Vascular, PC
St Louis, Missouri
Glacier View Research Institute
Kalispell, Montana
Bryan Heart
Lincoln, Nebraska
Wake Forest Baptist Health
Winston-Salem, North Carolina
Capital Area Research, LLC
Camp Hill, Pennsylvania
Carolina Heart Specialists
Lancaster, South Carolina
Stern Cardiovascular Center
Germantown, Tennessee
Clinical Advancement Center, PLLC
San Antonio, Texas
Corporation Lane Research Center
Virginia Beach, Virginia
Inst. de Cardiología de Corrientes Juana Francisca Cabral
Corrientes, Argentina
Centro de Investigaciones Clinicas del Litoral
Santa Fe, Argentina
Clínica DIM
Ramos Mejía, Buenos Aires, Argentina
Instituto de Investigaciones Clínicas San Nicolás
San Nicolás de los Arroyos, Buenos Aires, Argentina
Centro de Investigaciones Clínicas
Buenos Aires, Ciudad Auton. de Buenos Aires, Argentina
Centro de Medicina Integral e Investigacion Clínica
CABA, Ciudad Auton. de Buenos Aires, Argentina
Centro de Especialidades Médicas
Villa Luro, Ciudad Auton. de Buenos Aires, Argentina
Sanatorio Parque S.A.
Rosario, Santa Fe Province, Argentina
Zentrum f. klinische Studien Dr. Hanusch GmbH
Vienna, Austria
Universitätsklinikum AKH Wien
Vienna, Austria
Klinik Floridsdorf - Krankenhaus Nord
Vienna, Austria
Showing 40 of 177 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.